Physiological electric fields control the G1/S phase cell cycle checkpoint to inhibit endothelial cell proliferation

被引:51
作者
Wang, ET
Yin, YL
Zhao, M
Forrester, JV
McCaig, CD [1 ]
机构
[1] Univ Aberdeen, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland
[2] Univ Aberdeen, Sch Med, Dept Ophthalmol, Aberdeen AB25 2ZD, Scotland
关键词
bioelectricity; cell growth; cyclin; apoptosis;
D O I
10.1096/fj.02-0510fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial cell (VEC) proliferation is a key event in angiogenesis and is tightly regulated. Electric potential differences exist around the vascular endothelium and give rise to endogenous electric fields (EFs), whether these EFs influence VEC proliferation is unclear. We exposed cultured VECs to applied EFs of physiological strengths for up to 72 h. EF at 50 or 100 mV/mm did not influence cell proliferation, but at 200 mV/mm, cell density, cell growth rate, and mitosis index decreased significantly. EF-induced reduction in VEC proliferation was not due to increased apoptosis, because caspase apoptosis inhibitor Z-VAD-FMK (20 muM), had no effect on this response. Rather, EF responses were mediated via decreased entry of cells into S phase from G(1) phase, as shown by flow cytometry. Western blot showed that EFs decreased G(1)-specific cyclin E expression and increased cyclin/cyclin-dependent kinase complex inhibitor p27(kip1) expression. Thus EFs controlled VEC proliferation through induction of cell cycle arrest at G(1) by down-regulation of cyclin E expression and up-regulation of p27(kip1) expression, rather than by promoting apoptosis. If control of the cell cycle by endogenous EFs extends beyond VECs, this would be of widespread biological significance in vivo.
引用
收藏
页码:458 / +
页数:14
相关论文
共 42 条
[31]  
RYABY JT, 1998, CLIN ORTHOP S, V355, P205
[32]   MEASUREMENT OF STREAMING POTENTIALS OF MAMMALIAN BLOOD VESSELS AORTA AND VENA CAVA IN VIVO [J].
SAWYER, PN ;
HIMMELFARB, E ;
LUSTRIN, I ;
ZISKIND, H .
BIOPHYSICAL JOURNAL, 1966, 6 (05) :641-+
[33]   BIO-ELECTRIC PHENOMENA AS AN ETIOLOGIC FACTOR IN INTRAVASCULAR THROMBOSIS [J].
SAWYER, PN ;
PATE, JW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1953, 175 (01) :103-107
[34]   CDK inhibitors:: positive and negative regulators of G1-phase progression [J].
Sherr, CJ ;
Roberts, JM .
GENES & DEVELOPMENT, 1999, 13 (12) :1501-1512
[35]   Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagolation [J].
Spranger, J ;
Hammes, HP ;
Preissner, KT ;
Schatz, H ;
Pfeiffer, AFH .
DIABETOLOGIA, 2000, 43 (11) :1404-1407
[36]   A role for angiogenesis in rheumatoid arthritis [J].
Stupack, DG ;
Storgard, CM ;
Cheresh, DA .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (05) :573-581
[37]  
Szekanecz Z, 1998, J INVEST MED, V46, P27
[38]  
WRIGHT HP, 1972, ATHEROSCLEROSIS, V15, P93
[39]  
Yew PR, 2001, J CELL PHYSIOL, V187, P1, DOI 10.1002/1097-4652(2001)9999:9999<1::AID-JCP1049>3.0.CO
[40]  
2-O